Adenosine A1 Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Adenosine A1 Receptor (A1R) is a Gi/o protein-coupled receptor that inhibits adenylate cyclase, reduces cAMP levels, and hyperpolarizes neurons through GIRK channel activation. This 326-amino acid protein is the most abundant adenosine receptor in the brain and serves as the primary mediator of adenosine's inhibitory effects on neuronal excitability. A1R is widely expressed throughout the central and peripheral nervous systems, where it regulates neurotransmitter release, controls pain transmission, modulates sleep-wake cycles, and provides neuroprotection during metabolic stress. Dysregulation of A1R signaling contributes to epilepsy, chronic pain, sleep disorders, and neurodegenerative diseases.
A1R follows the canonical seven-transmembrane GPCR fold:
| Domain | Residues | Function |
|---|---|---|
| N-terminus | 1-50 | Extracellular, ligand access |
| TM1 | 51-75 | Helical bundle |
| TM2 | 76-99 | Helical bundle |
| TM3 | 100-129 | G protein coupling |
| TM4 | 130-154 | Helical bundle |
| TM5 | 155-181 | Ligand binding pocket |
| TM6 | 182-208 | Conformational changes |
| TM7 | 209-232 | Helical bundle |
| C-terminus | 233-326 | Intracellular, phosphorylation |
The orthosteric binding site is located within the transmembrane bundle:
A1R couples primarily to Gi/o proteins, activating multiple downstream pathways:
Adenosine binding → A1R conformational change → Gi/o activation
↓
┌─────────┴─────────┐
↓ ↓ ↓
Adenylyl GIRK N-type
cyclase channels Ca²⁺ channels
↓ ↓ ↓
cAMP↓ Hyperpolar- Ca²⁺ influx↓
ization
| Mechanism | Effect | Time Course |
|---|---|---|
| Phosphorylation | Desensitization | Minutes |
| Arrestin binding | Internalization | Minutes-hours |
| Receptor degradation | Downregulation | Hours-days |
| mRNA changes | Reduced expression | Hours-days |
A1R shows widespread but region-specific expression:
| Region | Density | Functional Implication |
|---|---|---|
| Cerebral cortex | High | General inhibition |
| Hippocampus | High | Memory modulation |
| Cerebellum | High | Motor coordination |
| Spinal cord | High | Pain processing |
| Thalamus | Moderate | Sensory gating |
| Basal ganglia | Moderate | Movement control |
A1R provides endogenous seizure protection:
A1R mediates adenosine-induced analgesia:
A1R alterations in AD and PD:
| Compound | Selectivity | Clinical Use |
|---|---|---|
| Adenosine | Non-selective | Cardiac arrhythmias |
| CCPA | A1 selective | Research tool |
| CPA | A1 selective | Research tool |
| Selodenoson | A1 selective | Clinical trials |
| Compound | Selectivity | Clinical Use |
|---|---|---|
| Caffeine | Non-selective | Wake promotion |
| Theophylline | Non-selective | Asthma, COPD |
| Rolofylline | A1 selective | Heart failure trials |
| BG9719 | A1 selective | Clinical trials |
The study of Adenosine A1 Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1]: https://pubmed.ncbi.nlm.nih.gov/10629201/ PMID:10629201
[2]: https://pubmed.ncbi.nlm.nih.gov/10816402/ PMID:10816402
[3]: https://pubmed.ncbi.nlm.nih.gov/15604288/ PMID:15604288
[4]: https://pubmed.ncbi.nlm.nih.gov/17585956/ PMID:17585956
[5]: https://pubmed.ncbi.nlm.nih.gov/19029120/ PMID:19029120
[6]: https://pubmed.ncbi.nlm.nih.gov/21885568/ PMID:21885568
[7]: https://pubmed.ncbi.nlm.nih.gov/22949693/ PMID:22949693
[8]: https://pubmed.ncbi.nlm.nih.gov/25666150/ PMID:25666150